Source Search Page

thumbnail favicon cgtlive.com > view

Paul Y. Song, MD, on Bringing SNK01 to Clinical Trials for Parkinson Disease

1+ day, 23+ hour ago — 

...Song, MD, the chairman and chief executive officer of NKGen, to learn... ...Following up on this news, CGTLive® reached out to Paul Y.... ..., PhD, the chief scientific officer of Precision for Medicine, discussed... ...month, with coverage highlights from the CGTLive® team. 2 Commerce Drive...

thumbnail favicon cgtlive.com > view

Second-Generation NK Cell Engager Heading to Trial for CD33+ Leukemia

1+ day, 19+ hour ago — 

..., Executive Chairman and Interim Chief Executive Officer, GT... ...2025 for GTB-5550, which will target multiple solid tumors”, Michael Breen... ...TRX103 for GvHD Prevention Tr1X reported that the first patient... ...month, with coverage highlights from the CGTLive® team. 2 Commerce Drive...

thumbnail favicon cgtlive.com > view

Lisa Nieland on Slowing Tumor Growth in Glioblastoma With Novel AAV Therapy

2+ day, 15+ hour ago — 

...School, at the American Society of Gene & Cell Therapy (ASGCT) 27th... ..., a PhD candidate from Lieden University Medical Center, is doing... ...to Grow Faraz Ali, MBA, the chief executive officer of Tenaya Therapeutics... ...and gene therapies. 2 Commerce Drive Cranbury, NJ 08512...

thumbnail favicon cgtlive.com > view

Manali Kamdar, MD, on Acclimating to Routine CAR T Practice in the Field

2+ day, 23+ hour ago — 

...Lisocabtagene maraleucel (liso-cel), approved under the name Breyanzi... ...Kamdar MK, Solomon SR, Arnason J, et al.... ...Presented at: 2024 (ASCO) Annual Meeting; May 31 - June 4; Chicago...

thumbnail favicon cgtlive.com > view

Around the Helix: Cell and Gene Therapy Company Updates – July 10, 2024

3+ day, 15+ hour ago — 

...Spur Therapeutics (formerly known as Freeline Therapeutics) has announced... ...Myrtelle Inc has announced that the FDA selected its investigational... ...to Grow Faraz Ali, MBA, the chief executive officer of Tenaya Therapeutics... ...UMass Chan Medical School has selected the contract development and...

thumbnail favicon cgtlive.com > view

Paul Y. Song, MD, on Using Autologous Natural Killer Cells to Treat Parkinson Disease

3+ day, 23+ hour ago — 

...NKGen Biotech, on the other hand, is currently developing SNK01,... ...originally developed by the company for oncology indications, NKGen... ...Song, MD, the chairman and chief executive officer of NKGen, to get... ..., PhD, the chief scientific officer of Precision for Medicine, discussed...

thumbnail favicon cgtlive.com > view

Jennifer Taylor-Cousar, MD, MSCS, on Early Signals of Efficacy With Cystic Fibrosis Gene Therapy

4+ day, 12+ hour ago — 

...CGTLive spoke with Taylor-Cousar to learn more about the progress... ...Cord Blood Derived Cells for the Treatment of Preterm Infants Atul Malhotra... ...Gene Editing Trial Underway in Pediatric Methylmalonic Acidemia The... ...via synthetic AAV vectors. 2 Commerce Drive Cranbury, NJ 08512...

thumbnail favicon cgtlive.com > view

Data Roundup: June 2024 Features Updates from ASCO and in Diabetes, Rare Disease, and more.

4+ day, 19+ hour ago — 

...of Clinical Oncology (ASCO) Annual Meeting as well in diabetes... ...month delivered promising data updates presented at the 2024 American Society... ...and Islet Transplant Program, University of Chicago, Illinois, said... ...and gastrointestinal oncologist at Dana-Farber Cancer Institute,...

thumbnail favicon cgtlive.com > view

Leigh Ramos-Platt, MD, on Looking Forward to Gene Therapy’s Growth

4+ day, 23+ hour ago — 

...Leigh Ramos-Platt, MD, Medical Director, Muscular Dystrophy Association... ...and Pediatrics, Keck School of Medicine, University of Southern... ...to Grow Faraz Ali, MBA, the chief executive officer of Tenaya Therapeutics... ...Ocugen Doses First Patient With Retinitis Pigmentosa Gene Therapy...

 


**Content is provided on an “as is” basis. 4Internet, LLC makes no commitments regarding the content. What you see here may not be accurate and should not be relied upon. The content does not necessarily represent the views and opinions of 4Internet, LLC. You use this service and everything you see here at your own risk.